Loading market intelligence…
Cedar Bio is a fictional biotechnology company used to demonstrate SVI's private-market intelligence tools. All financing, valuation and investor relationships on this profile are illustrative.
Cedar Bio is a fictional biotechnology company used to demonstrate SVI's private-market intelligence tools. All financing, valuation and investor relationships on this profile are illustrative.
Position by illustrative valuation within the tracked sector.
Explore sector ↗| 2026-07-18 | Series C+ | $93M | $10.5B | Signal Peak Capital | Pacific Foundry Ventures, Northstar Ventures | Demo · Unverified |
| 2025-08-12 | Series A | $30M | Not disclosed | Signal Peak Capital | Pacific Foundry Ventures, Northstar Ventures | Demo · Unverified |
| 2024-11-08 | Seed | $6M | Not disclosed | Signal Peak Capital | Pacific Foundry Ventures, Northstar Ventures | Demo · Unverified |
Illustrative founding year
| Helix Discovery | Biotech | $36.1B | $483M | Growth |
| Cellular Atlas | Biotech | $16.3B | $204M | Series C+ |
| Oak Bio | Biotech | $7.8B | $95M | Series B |
| Juniper Bio | Biotech | $6.2B | $75M | Series B |
All metrics on this profile originate in the SVI illustrative dataset. Published and retrieved Sep 18, 2026. Last verified: not verified. No original external publication exists for synthetic records.
Demo dataset · Sep 18, 2026